Hoth Therapeutics (HOTH) Q3 2024 Earnings

9AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-1.16
-0.85
-0.55
-0.24

Details

Expected EPS
-0.24
Actual EPS
-0.24
Surprise EPS
0
Surprise Percent
+0%

Description

Hoth Therapeutics (HOTH) has reported earnings of -0.24 per share for Q3 2024.

0 Comments

Share your thoughts